AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 23, 16:00
AnGes SG&A Expense (Quarterly): 10.62M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.62M |
December 31, 2023 | 9.706M |
September 30, 2023 | 11.08M |
June 30, 2023 | 9.704M |
March 31, 2023 | 10.97M |
December 31, 2022 | 9.864M |
September 30, 2022 | 10.12M |
June 30, 2022 | 9.473M |
March 31, 2022 | 10.98M |
December 31, 2021 | 10.36M |
September 30, 2021 | 9.901M |
June 30, 2021 | 12.53M |
March 31, 2021 | 11.49M |
December 31, 2020 | 7.955M |
September 30, 2020 | 3.019M |
June 30, 2020 | 2.982M |
March 31, 2020 | 3.196M |
December 31, 2019 | 2.615M |
September 30, 2019 | 3.188M |
June 30, 2019 | 3.676M |
March 31, 2019 | 2.399M |
December 31, 2018 | 1.900M |
September 30, 2018 | 2.169M |
June 30, 2018 | 2.442M |
March 31, 2018 | 2.077M |
Date | Value |
---|---|
December 31, 2017 | 1.627M |
September 30, 2017 | 2.652M |
June 30, 2017 | 1.751M |
March 31, 2017 | 1.787M |
December 31, 2016 | 2.006M |
September 30, 2016 | 2.190M |
June 30, 2016 | 2.201M |
March 31, 2016 | 2.028M |
December 31, 2015 | 2.107M |
September 30, 2015 | 1.522M |
June 30, 2015 | 1.663M |
March 31, 2015 | 2.065M |
December 31, 2014 | 1.584M |
September 30, 2014 | 1.796M |
June 30, 2014 | 1.521M |
March 31, 2014 | 1.66M |
December 31, 2013 | 1.707M |
September 30, 2013 | 1.603M |
June 30, 2013 | 1.689M |
March 31, 2013 | 2.193M |
December 31, 2012 | 2.659M |
September 30, 2012 | 2.877M |
June 30, 2012 | 2.750M |
March 31, 2012 | 3.004M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.615M
Minimum
Dec 2019
12.53M
Maximum
Jun 2021
8.171M
Average
9.785M
Median
SG&A Expense (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 1.922B |
Nxera Pharma Co Ltd | 24.59M |
PeptiDream Inc | 12.68M |
Healios KK | 2.520M |
SanBio Co Ltd | 2.813M |